WELL Health Technologies Corp.
WHTCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.03 | -0.17 | -0.02 | 0.40 |
| FCF Yield | 1.48% | 2.08% | 1.54% | -6.27% |
| EV / EBITDA | 35.72 | 24.59 | -111.28 | -95.28 |
| Quality | ||||
| ROIC | -0.75% | 1.19% | 0.50% | -2.75% |
| Gross Margin | 38.19% | 44.51% | 39.94% | 21.30% |
| Cash Conversion Ratio | 6.52 | 1.61 | -0.51 | 3.23 |
| Growth | ||||
| Revenue 3-Year CAGR | 16.39% | 19.47% | 17.08% | 17.35% |
| Free Cash Flow Growth | -35.48% | 34.53% | 114.63% | -301.13% |
| Safety | ||||
| Net Debt / EBITDA | 10.50 | 7.73 | -29.39 | -13.80 |
| Interest Coverage | 1.85 | 2.91 | 0.70 | -7.46 |
| Efficiency | ||||
| Inventory Turnover | 100.69 | 69.35 | 56.48 | 56.52 |
| Cash Conversion Cycle | 12.10 | 5.71 | 14.47 | 43.78 |